Who invested in Aravax?
2 investors are on record as having backed Aravax — Peanut allergy immunotherapy, in Biotech, Australia. Each row below says whether the round came from the investor's own portfolio page or from the press.
aravax.com.auAravax investors
Breakthrough VictoriaProvides long-term patient capital to innovation businesses tackling major challenges in…their site
Uniseed VenturesBacks university-originated deep tech and life sciences from lab to global scale,…their site
No round dates are on record for Aravax. A portfolio page names its companies far more often than it dates the cheque, and we would rather leave the field empty than guess it.
The funds that backed Aravax are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.